José Luis Zamorano

TL;DR: The current review will describe both normal and pathologic tricuspid valvular anatomy, the classification of these anatomic substrates of TR, the strengths and limitations of the current guidelines-recommended multi-parametric echocardiographic approach and the role of multi-modality imaging, as well as the roles of transcatheter device therapy in the management of the disease.

TL;DR: Advances in cancer treatments have improved clinical outcomes, leading to an increasing population of cancer survivors, but this success is associated with high rates of short‐ and long‐term cardiovascular toxicities, which has led to the development of the cardio‐oncology subspecialty.

TL;DR: TAPSE measurement is the least user dependent and most reproducible echocardiographic finding of RV dysfunction in normotensive patients with PE.

TL;DR: The ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death were published in 2015 as mentioned in this paper, and the ESC Task Force for the Management of Patients with Ventricular Arrhythmia and the Prevention of Sudden Cardiac Death of the European Society of Cardiology

TL;DR: Significant TR is a prevalent condition and a high proportion of these patients have an indication for valve intervention, and more than a half of patients with severe, massive, or torrential TR had a high surgical risk.